A Drug Interaction Study of SY-004 Capsules in Healthy Subjects

NCT04907019 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: rifampicin，SY-004

Sponsor

Suzhou Yabao Pharmaceutical R&D Co., Ltd.